| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/09/2006 | US20060030022 Compositions and methods for production of disulfide bond containing proteins in host cells |
| 02/09/2006 | US20060030019 HDAC9 polypeptides and polynucleotides and uses thereof |
| 02/09/2006 | US20060030015 Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof |
| 02/09/2006 | US20060030008 kit for purifying a recombinant fusion protein containing a DNA expression vector plasmid having a sequence encoding a mutant chitin-binding domain capable of reversible binding under non-denaturing conditions |
| 02/09/2006 | US20060030007 Peptides for metal ion affinity chromatography |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030004 Solid phase synthesis |
| 02/09/2006 | US20060030003 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |
| 02/09/2006 | US20060030002 Isoforms of the human Vitamin D receptor |
| 02/09/2006 | US20060030001 Useful polypeptides |
| 02/09/2006 | US20060030000 Growth factor binding constructs materials and methods |
| 02/09/2006 | US20060029999 Nucleic acid sequences having an activity of regulating translation efficiency and utilization thereof |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029997 nucleic acid sequence encoding an adhesive protein derived from a mollusk foot protein(MEFP-1); waterproof adhesives |
| 02/09/2006 | US20060029996 CDNA, or expression vector comprising the nucleotide sequence linked to an expression control sequence; biosynthesis of waterproof bioadhesive proteins, adhesins; high strength, durability |
| 02/09/2006 | US20060029995 Novel class of metacaspases |
| 02/09/2006 | US20060029984 PSP94 diagnostic reagents and assays |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029947 Combinatorial protein library screening by periplasmic expression |
| 02/09/2006 | US20060029945 Novel full length cDNA |
| 02/09/2006 | US20060029940 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 02/09/2006 | US20060029939 Decomposition and modification of silicate and silicone by silase and use of the reversible enzyme |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029619 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 02/09/2006 | US20060029604 Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform |
| 02/09/2006 | US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 02/09/2006 | US20060029599 Lyophilizing an aqueous formulation comprising a high concentration, 50 mg/ml or more of an immunoglobulin IgG antibody, in particular, daclizumab, in 5-25 mM histidine buffer, having pH 5.5-6.5, 0.005%-0.03% polysorbate, and sucrose |
| 02/09/2006 | US20060029595 Methods of using human receptor protein 4-1BB |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | US20060029590 Administration of neutral endopeptidase to treat inflammatory bowel disease |
| 02/09/2006 | US20060029588 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 02/09/2006 | US20060029547 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 02/09/2006 | CA2576037A1 Method of producing glycoprotein composition |
| 02/09/2006 | CA2575714A1 Yeast promoter |
| 02/09/2006 | CA2574953A1 Process for improved protein expression by strain engineering |
| 02/09/2006 | CA2574496A1 Methods for diagnosis using anti-cytokine receptor antibodies |
| 02/08/2006 | EP1624068A1 Genetic immunization with cationic lipids |
| 02/08/2006 | EP1623990A2 Compositions and methods for the treatment of tumours |
| 02/08/2006 | EP1623989A1 Compositions and methods for the diagnosis of tumours |
| 02/08/2006 | EP1623988A1 Protein refolding apparatus and method of using the same |
| 02/08/2006 | EP1623232A2 Enrichment of enzymatic cleavage products |
| 02/08/2006 | EP1623221A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function |
| 02/08/2006 | EP1623038A2 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 02/08/2006 | EP1623011A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| 02/08/2006 | EP1622928A2 Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
| 02/08/2006 | EP1622921A2 Variants of beta-glucosidases |
| 02/08/2006 | EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1337651B1 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 02/08/2006 | EP1114062B1 Modified e.coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0946735B1 N-terminally extended proteins expressed in yeast |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/08/2006 | EP0783527B1 Cathepsin o2 protease |
| 02/08/2006 | EP0765391B1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/2006 | EP0694067B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 02/08/2006 | EP0648266B1 Elicitor of the hypersensitive response in plants |
| 02/08/2006 | CN1732259A Method of degrading hardly degradable protein |
| 02/08/2006 | CN1732258A High expression locus vector based on ferritin heavy chain gene locus |
| 02/08/2006 | CN1730492A Single-chain antibody for lactoferrin , method for making same and uses |
| 02/08/2006 | CN1240843C Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240831C Method for producing heterologous secreting protein from Chinese hamster ovary cells grown on microcarriers |
| 02/08/2006 | CN1240716C Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 02/07/2006 | US6996472 Drift compensation method for fingerprint spectra |
| 02/07/2006 | US6995250 Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 02/07/2006 | US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries |
| 02/07/2006 | US6995239 An amino acid sequence of a protein which is capable of modulating hyphal growth in fungus, e.g. Aspergillus; controlling gene expression; plant growth regulators; fungicides |
| 02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
| 02/07/2006 | US6995004 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT |
| 02/07/2006 | US6994997 Gram positive bacteria deprived of HtrA protease activity and their uses |
| 02/07/2006 | US6994996 polypeptide able to regulate ATPase activity; use treating various disease such as malignant tumors, hemopathies, HIV infections, immune diseases and inflammations |
| 02/07/2006 | US6994995 Specified sequences; expression vectors and host cells; share sequence similarity with mammalian synaptotagmins which have been implicated in membrane traffic and calcium dependent neuroexocytosis and are drug targets |
| 02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
| 02/07/2006 | US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 02/07/2006 | US6994992 Nucleic acid encoding the novel tumor suppressor gene termed "Androgen Shutoff Gene 3" (AS3); prostate cancer drug target; marker for the efficient diagnosis and treatment of prostate cancer; host cell, vector, and kit for measuring AS3 |
| 02/07/2006 | US6994990 Active modified hedgehog proteins |
| 02/07/2006 | US6994988 Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 02/07/2006 | US6994987 Process for producing tripeptides |
| 02/07/2006 | US6994986 Generation of preferential polypeptides; generate reaction mixtures, insert amino acid, recover polypeptides |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994975 Expression and purification of ATM protein using vaccinia virus |
| 02/07/2006 | US6994968 BK beta subunits of Slo family potassium channels |
| 02/07/2006 | US6994963 Methods for recombinatorial nucleic acid synthesis |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/02/2006 | WO2006012288A1 Enzymatic process to produce highly functional soy protein from crude soy material |
| 02/02/2006 | WO2006011589A1 Method of preparing artificial gene population and artificial protein population by random polymerization of motif sequences of multiple types |
| 02/02/2006 | WO2005001038A3 Recombinant anti-cd30 antibodies and uses thereof |
| 02/02/2006 | WO2003102166A3 Novel flavivirus antigens |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026719 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 02/02/2006 | US20060026706 Method for marker-less integration of a sequence of interest into the genome of a cell |
| 02/02/2006 | US20060026698 Transgenic transchromosomal rodents for making human antibodies |
| 02/02/2006 | US20060026696 Humanized immunoglobulin loci |
| 02/02/2006 | US20060026695 Transgenically produced fusion proteins |
| 02/02/2006 | US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences |
| 02/02/2006 | US20060025580 Novel human estrogen receptor beta |